Related MeSH Hierarchy (5)
Analytical, Diagnostic and Therapeutic Techniques, and Equipment [E] » Diagnosis [E01] » Diagnostic Techniques and Procedures » Physical Examination » Body Constitution » Physical Appearance, Body » Body Weight » Overweight
Phenomena and Processes [G] » Physiological Phenomena [G07] » Body Constitution » Physical Appearance, Body » Body Weight » Overweight
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Overnutrition » Overweight
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight » Overweight
Phenomena and Processes [G] » Physiological Phenomena [G07] » Body Constitution » Body Weights and Measures » Body Size » Body Weight » Overweight
Description
A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat". MeSH
Hierarchy View
Subtype Terms (1)
Obesity
927 drugs (359 approved, 568 experimental)
Phase 4 Indicated Drugs (23)
Phase 3 Indicated Drugs (19)
Phase 2 Indicated Drugs (29)
Phase 1 Indicated Drugs (24)
Other Experimental Indicated Drugs (99)
Organization Involved with Phase 4 Indications (64)
Aristotle University of Thessaloniki
Canadian Institutes of Health Research (CIHR)
Catholic University of Sacred Heart, Rome
Katholieke Universiteit Leuven
Les Laboratoires des Médicaments Stériles
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People's Liberation Army of China
Steno Diabetes Center Copenhagen
The University of Texas, Dallas
Thrombolysis In Myocardial Infarction Academic Research Organization
Organization Involved with Phase 3 Indications (54)
Huazhong University of Science and Technology
Jaeb Center for Health Research
Jiangsu Kanion Pharmaceutical Co., Ltd
Juvenile Diabetes Research Foundation
Organization Involved with Phase 2 Indications (65)
All India Institute of Medical Sciences
American Institute for Cancer Research (AICR)
Breast Cancer Research Foundation
Brookhaven National Laboratory
Canadian Center for Functional Medicine
High Point Pharmaceuticals, LLC.
Innovent Biologics (Suzhou) Co. Ltd.
Institut Hospital del Mar d'Investigacions Mèdiques
Metabolic Center of Louisiana Research Foundation
National Center for Research Resources (NCRR)
OAXACA SITE MANAGEMENT ORGANIZATION, SC
Pharmacology Research Institute
Satiogen Pharmaceuticals, Inc.
Spaulding Clinical Research Inc.
The Scientific and Technological Research Council of Turkey
Organization Involved with Phase 1 Indications (36)
Organization Involved with Other Experimental Indications (173)
Alliance for Potato Research and Education
Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento
California State Polytechnic University, Pomona
California Strawberry Commission
Central Jutland Regional Hospital
China Academy of Chinese Medical Sciences
Clinical Hospital Center Zemun
Community Health Center of Franklin County
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Diabetes Research Foundation, Finland
Federal University of Rio de Janeiro
Finnish Foundation for Cardiovascular Research
Fundación Cardiovascular de Colombia
German Diabetes Foundation, Munich, Germany
German Institute of Human Nutrition
Glycemic Index Laboratories, Inc
Illinois Institute of Technology
Instituto Nacional de Cardiologia Ignacio Chavez
King George's Medical University
Klinikum Ernst von Bergmann Augenklinik Laserzentrum
Morinaga Milk Industry Co. Ltd., Japan
National Cancer Institute (NCI)
National Institute of Nutrition, Vietnam
National University of Ireland
National Watermelon Promotion Board
New York Obesity and Nutrition Research Center
Regional Research Fund Western Norway
Rio de Janeiro State University
Scottish Universities Environmental Research Centre
Swiss Federal Institute of Technology
Technical University of Denmark
Technical University of Munich
TERME DI CHIANCIANO Spa, Italy
The Adelaide and Meath Hospital
The Baruch Padeh Medical Center, Poriya
Top Institute Food and Nutrition
Translational Research Institute for Metabolism and Diabetes, Florida
Universidad Industrial de Santander
University Hospital of North Norway
University of Alabama, Birmingham
University of California, Davis
University of California, Los Angeles
University of Roma La Sapienza
University of Southern California
Urmia University of Medical Sciences
U.S. Highbush Blueberry Council
Vita-Salute University of Milano. Italy
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
